Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
archive
guardant health
medicine
accuracy and precision
biotech
blood pressure medication
boston blog main
business
business sponsored company news
cancer diagnostics
evidence-based medicine
freenome
fundings & exits
grail
health
life sciences
liquid biopsy
losartan
lucence
medical
national blog main
recall
research
san francisco
san francisco blog main
san francisco top stories
systems biology
tc
thrive earlier detection
What
announced
6
×
blood
6
×
cancer
6
×
fda
biopsy
company
expands
medicine
pharmaceuticals
pressure
recall
screening
today
track
treatment
administration
analysis
approval
april
area
atlas
based
bay
bee
biomedical
brand
bridges
bruce
buildout
called
capital
causing
center
close
commercial
congress
data
determine
developing
discovered
Language
unset
Current search:
blood
×
cancer
×
announced
×
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@bgr.com
4 years ago
FDA expands recall of blood pressure meds due to cancer-causing impurity
@slashgear.com
4 years ago
The FDA just fast-tracked this new blood cancer treatment
@slashgear.com
4 years ago
Blood pressure medication recall expands over cancer risk
@venturebeat.com
7 years ago
Seven Bridges to Present on Cancer Moonshot’s Blood Profiling Atlas at Precision Medicine World Congress
@techcrunch.com
9 years ago
Guardant Health Secures $50 Million In Series C To Help More Doctors Track Cancer In Real Time